• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃内pH值对地高辛生物转化的影响。I. 胃内水解作用。

Influence of gastric pH on digoxin biotransformation. I. Intragastric hydrolysis.

作者信息

Gault H, Kalra J, Ahmed M, Kepkay D, Barrowman J

出版信息

Clin Pharmacol Ther. 1980 Jan;27(1):16-21. doi: 10.1038/clpt.1980.3.

DOI:10.1038/clpt.1980.3
PMID:7351113
Abstract

3H-digoxin-12 alpha and unlabeled digoxin were administered down a nasogastric tube and digoxin, digoxyigenin and its mono- and bis-digitoxosides, and pH were assayed in gastric fluid of 6 healthy subjects at intervals for 90 min each under 4 conditions: pentagastrin infusion 6 micrograms/kg/hr with the subjects ambulatory and supine, and saline infusion ambulatory and supine. Intragastric hydrolysis occurred at roughly the same rate as reported in vitro. At 90 min, an average of 12.5% of the radioactivity that remained in the gastric fluid was recovered as digoxin for the 2 conditions when pentagastrin was infused, compared with 52.5% for th 2 conditions when saline was infused. The main glycosidic metabolite was digoxigenin and the amount correlated closely with the hydrogen ion activity in gastric fluid at 90 min (r = 0.83, p less than 0.01). Only minor differences were found between the supine and ambulatory conditions. The clinical significance of these results remains to be determined.

摘要

将3H-地高辛-12α和未标记的地高辛经鼻胃管给药,在4种条件下,对6名健康受试者的胃液每隔一段时间进行90分钟的检测,测定其中地高辛、洋地黄毒苷及其单洋地黄毒糖苷和双洋地黄毒糖苷以及pH值:静脉输注五肽胃泌素6微克/千克/小时,受试者活动和仰卧状态,以及静脉输注生理盐水,受试者活动和仰卧状态。胃内水解发生的速率与体外报道的大致相同。90分钟时,在输注五肽胃泌素的2种条件下,胃液中残留放射性的平均12.5%以地高辛形式回收,而在输注生理盐水的2种条件下,这一比例为52.5%。主要的糖苷代谢产物是洋地黄毒苷,其含量与90分钟时胃液中的氢离子活性密切相关(r = 0.83,p < 0.01)。仰卧和活动状态之间仅发现微小差异。这些结果的临床意义尚待确定。

相似文献

1
Influence of gastric pH on digoxin biotransformation. I. Intragastric hydrolysis.胃内pH值对地高辛生物转化的影响。I. 胃内水解作用。
Clin Pharmacol Ther. 1980 Jan;27(1):16-21. doi: 10.1038/clpt.1980.3.
2
Influence of gastric pH on digoxin biotransformation. II. Extractable urinary metabolites.胃内pH值对地高辛生物转化的影响。II. 可提取的尿代谢物。
Clin Pharmacol Ther. 1981 Feb;29(2):181-90. doi: 10.1038/clpt.1981.29.
3
Hydrolysis of digoxin by acid.地高辛的酸水解
J Pharm Pharmacol. 1977 Jan;29(1):27-32. doi: 10.1111/j.2042-7158.1977.tb11232.x.
4
Digoxin degradation in acidic dissolution medium.地高辛在酸性溶解介质中的降解
J Pharm Sci. 1980 Apr;69(4):410-3. doi: 10.1002/jps.2600690412.
5
Kinetics of digoxin stability in aqueous solution.地高辛在水溶液中的稳定性动力学
J Pharm Sci. 1978 Mar;67(3):327-30. doi: 10.1002/jps.2600670313.
6
Autopsy verification of suicide by digitalis. Report of a case, with successful chemical identification of digitalis glycosides in gastric contents.洋地黄中毒自杀的尸检证实。病例报告,胃内容物中洋地黄苷的化学鉴定成功。
Am J Clin Pathol. 1967 Feb;47(2):180-5. doi: 10.1093/ajcp/47.2.180.
7
Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver microsomes.地高辛、洋地黄毒苷元和洋地黄毒苷在人肝细胞和肝微粒体中的代谢。
Fundam Clin Pharmacol. 1991;5(7):567-82. doi: 10.1111/j.1472-8206.1991.tb00746.x.
8
Digoxin biotransformation.地高辛的生物转化
Clin Pharmacol Ther. 1984 Jan;35(1):74-82. doi: 10.1038/clpt.1984.11.
9
The reactivity of derivatives of digoxin and digitoxin as measured by the Na-K-atpase displacement assay and by radioimmunoassay.通过钠钾 - ATP酶置换试验和放射免疫测定法所测得的地高辛和洋地黄毒苷衍生物的反应活性。
J Lab Clin Med. 1975 Apr;85(4):610-20.
10
Digoxigenin biotransformation.洋地黄毒苷元生物转化
Clin Pharmacol Ther. 1982 Jun;31(6):695-704. doi: 10.1038/clpt.1982.98.

引用本文的文献

1
Interaction between Chinese medicine and digoxin: Clinical and research update.中药与地高辛的相互作用:临床与研究进展
Front Pharmacol. 2023 Feb 7;14:1040778. doi: 10.3389/fphar.2023.1040778. eCollection 2023.
2
The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.通过特定的高效液相色谱法测定的三种口服制剂中地高辛的生物利用度。
Br J Clin Pharmacol. 1993 Feb;35(2):136-42. doi: 10.1111/j.1365-2125.1993.tb05679.x.
3
Metabolism of digoxin after oral and intrajejunal administration.口服和空肠内给药后地高辛的代谢
Br J Clin Pharmacol. 1983 Dec;16(6):741-2. doi: 10.1111/j.1365-2125.1983.tb02255.x.
4
Fasting and postprandial absorption of digoxin from a microencapsulated formulation.地高辛微囊制剂的空腹及餐后吸收情况
Eur J Clin Pharmacol. 1983;25(2):207-10. doi: 10.1007/BF00543792.
5
Increased metabolism to dihydrodigoxin after intake of a microencapsulated formulation of digoxin.摄入地高辛微囊制剂后二氢地高辛的代谢增加。
Eur J Clin Pharmacol. 1984;27(2):197-202. doi: 10.1007/BF00544045.
6
Reduction of digoxin to 20R-dihydrodigoxin by cultures of Eubacterium lentum.迟缓真杆菌培养物将地高辛还原为20R-二氢地高辛。
Appl Environ Microbiol. 1986 Jun;51(6):1300-3. doi: 10.1128/aem.51.6.1300-1303.1986.
7
Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose.多次服用奥美拉唑对单次口服地高辛药代动力学的轻微影响。
Br J Clin Pharmacol. 1991 Nov;32(5):569-72. doi: 10.1111/j.1365-2125.1991.tb03953.x.
8
Omeprazole drug interaction studies.奥美拉唑药物相互作用研究。
Clin Pharmacokinet. 1991 Sep;21(3):195-212. doi: 10.2165/00003088-199121030-00004.